NCT02664961 2019-07-23Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN)Tracon Pharmaceuticals Inc.Phase 2 Terminated3 enrolled 11 charts
NCT01778530 2015-10-07TRC105 for Recurrent GlioblastomaNational Institutes of Health Clinical Center (CC)Phase 2 Terminated2 enrolled 9 charts